Related Experiment Video
Updated: Apr 6, 2026

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
Published on: May 9, 2025
Synthetic biology approaches to engineer T cells
Chia-Yung Wu1, Levi J Rupp1, Kole T Roybal1
1Dept. of Cellular & Molecular Pharmacology, University of California San Francisco, San Francisco, CA 94158, United States.
None:
There is rapidly growing interest in learning how to engineer immune cells, such as T lymphocytes, because of the potential of these engineered cells to be used for therapeutic applications such as the recognition and killing of cancer cells. At the same time, our knowhow and capability to logically engineer cellular behavior is growing rapidly with the development of synthetic biology. Here we describe how synthetic biology approaches are being used to rationally alter the behavior of T cells to optimize them for therapeutic functions. We also describe future developments that will be important in order to construct safe and precise T cell therapeutics.

